CompletedPhase 3NCT00906685

Bevacizumab for Central Retinal Vein Occlusion Study

Studying Central retinal vein occlusion

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Anders Kvanta
Principal Investigator
Anders Kvanta, MD, PhD
St Eriks Eye Hospital
Intervention
bevacizumab(drug)
Enrollment
60 enrolled
Eligibility
All sexes
Timeline
20092011

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00906685 on ClinicalTrials.gov

Other trials for Central retinal vein occlusion

Additional recruiting or active studies for the same condition.

See all trials for Central retinal vein occlusion

← Back to all trials